Article Versions Notes

Alrubie TM, Alamri AM, Almutairi BO, Alrefaei AF, Arafah MM, Alanazi M, Semlali A, Almutairi MH. Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation. Medicina. 2023; 59(5):988. https://doi.org/10.3390/medicina59050988

Alrubie, Turki M., Abdullah M. Alamri, Bader O. Almutairi, Abdulwahed F. Alrefaei, Maha M. Arafah, Mohammad Alanazi, Abdelhabib Semlali, and Mikhlid H. Almutairi. 2023. "Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation" Medicina 59, no. 5: 988. https://doi.org/10.3390/medicina59050988

Alrubie, T. M., Alamri, A. M., Almutairi, B. O., Alrefaei, A. F., Arafah, M. M., Alanazi, M., Semlali, A., & Almutairi, M. H. (2023). Higher Expression Levels of SSX1 and SSX2 in Patients with Colon Cancer: Regulated In Vitro by the Inhibition of Methylation and Histone Deacetylation. Medicina, 59(5), 988. https://doi.org/10.3390/medicina59050988